Extraordinary Shareholders' Meeting of April 6, 2020 behind closed doors

In the context of the Covid-19 epidemic and in accordance with the measures taken by the government to stop the virus proliferation, the Board of Directors has decided to hold the general meeting exceptionally outside the physical presence of shareholders and all other persons entitled to attend (included auditors).

Read the press release (in French)


Invitation to the Extraordinary Shareholders' Meeting of April 6, 2020

Availability of preparatory documents for the Annual General Meeting and remote participation details.

Read the press release (in French)


Number of shares and voting rights as at 29/02/2020

Europlasma declares the number of voting rights and shares comprising its share capital as at 29th Frebruary.

Read the press release (in French)


Consolidation of shares planned and equity financing secured

  • Extraordinary General Meeting convened on April 6, 2020
  • Plan to reduce share capital by charging losses
  • Plan to consolidate of shares
  • Authorization to finance future projects
  • Confirmation of the drawdown capacity of tranches 5 and 6 of the OCABSA financing

Read the press release (in French)


Number of shares and voting rights as at 31/01/2020

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.

Read the press release (in French)


Number of shares and voting rights as at 31/12/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.

Read the press release (in French)


Ordinary General Meeting of Shareholders holds on 20 Dec. 2019

All resolutions proposed to the General Meeting of Shareholders on 20 December 2019 have been approuved.

See all documents regarding the OGM (in French)


Drawdown details of the 3rd tranche of 200 convertible bonds

Waiver of conditions precedent on the part of the investor

Read the press release (in French)


Number of shares and voting rights as at 30/11/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November.

Read the press release (in French)


Ordinary Shareholders' Meeting of November 29, 2019

• Quorum not reached
• Second call of the Ordinary General Meeting on December 20, 2019

Read the press release (in French)